For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Threshold Pharmaceuticals, Inc.

USPTO Granted Patents = 19

% Expired Patents = 42.1

CIPO Patents = 2

EPO Patents = 9

Trademarks = 2

Forward Citations = 203

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Mark D Matteucci (12 out of 65 patents)

Jian-Xin Duan (10 out of 18 patents)

George Tidmarsh (7 out of 17 patents)

4. Hailong Jiao (6 out of 12 patents)

5. Photon Rao (3 out of 4 patents)

6. Charles Praray Hart (2 out of 5 patents)

7. Stewart Kroll (2 out of 3 patents)

8. Jacob Kaizerman (2 out of 2 patents)

9. Tao Chen (1 out of 227 patents)

10. Yeyu Cao (1 out of 7 patents)

11. Xiaohong Cai (1 out of 7 patents)

12. Fanying Meng (1 out of 1 patent)

13. Jessica Sun (1 out of 1 patent)

14. John G Curd (1 out of 1 patent)

15. Damian Handisides (1 out of 1 patent)

19 patents: Sort by Forward Citations

1. 9254299 - Administration of hypoxia activated prodrugs in combination with Chk1 inhibitors for treating cancer (2016-02-09),

2. 9226932 - Phosphoramidate alkylator prodrugs (2016-01-05),

3. 9205098 - Anti-cancer therapies (2015-12-08),

4. 8946275 - Treatment of cancer using hypoxia activated prodrugs (2015-02-03),

5. 8765690 - Treatment of cancer with glufosfamide in patients not receiving insulin therapy (2014-07-01),

6. 8664204 - Phosphoramidate alkylator prodrugs (2014-03-04),

7. 8575188 - Camptothecin derivatives (2013-11-05),

8. 8552048 - Phosphoramidate alkylator prodrugs for the treatment of cancer (2013-10-08),

9. 8507464 - Phosphoramidate alkylator prodrugs (2013-08-13),

10. 8318683 - Anti-cancer therapies (2012-11-27),

11. 8309554 - Hypoxia activated drugs of nitrogen mustard alkylators (2012-11-13),

12. 8299088 - Compositions and methods for treating cancer (2012-10-30),

13. 8003625 - Phosphoramidate alkylator prodrugs (2011-08-23),

14. 7560230 - Method for determining susceptibility of tumor to treatment with anti-neoplastic agent (2009-07-14),

15. 7550496 - Compositions and methods for treating cancer (2009-06-23),

Threshold Pharmaceuticals, Inc. is a biotechnology company that focuses on the discovery and development of innovative medicines for the treatment of cancer. With a dedicated team of scientists and researchers, Threshold Pharmaceuticals aims to improve patient outcomes by delivering targeted therapies that address the underlying mechanisms of cancer. Visit their website to learn more about their groundbreaking research and pipeline of potential cancer treatments.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

19 Patents

#67 in South San Francisco, CA

#4,091 in California

#17,096 in US

#32,555 in the World

South San Francisco, CA, United States of America

Threshold Pharmaceuticals, Inc.

Forward Citations = 203

19 inventors:

Mark D Matteucci (12 out of 65 patents)

Jian-Xin Duan (10 out of 18 patents)

George Tidmarsh (7 out of 17 patents)

4. Hailong Jiao (6 out of 12 patents)

5. Photon Rao (3 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…